UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA.

Autor: Pulsoni, A., Tosti, M. E., Ferrero, S., Luminari, S., Dondi, A., Liberati, A. M., Cenfra, N., Renzi, D., Zanni, M., Boccomini, C., Ferreri, A. J., Rattotti, S., Zilioli, V. R., Bernuzzi, P., Bolis, S., Musuraca, G., Nassi, L., Perrone, T., Stelitano, C., Anastasia, A.
Zdroj: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
Databáze: Complementary Index